Hold at $543 — Defer initiation until $539 support confirms with volume and clean trial week
Hold at $543 is the calibrated decision: the trader's architecture is sound in principle but miscalibrated in timing. Technical structure is more bearish (close below lower Bollinger band, MACD expanded 235% to minus 3.19, all MAs sloping down at $578/$597/$625, RSI 36), the binary catalyst has expanded from 24-48 hours to multi-week overhang with daily optional adverse jury signal risk, and Jackson Hole (Aug 28) adds hawkish Warsh speech as multiple-compressor for duration-sensitive mega-cap tech. The structural case (PEG 0.88, $90B cash fortress, 27.9% revenue acceleration) is genuinely rare but entry should wait for $539 confirmation with volume and clean initial trial week — the 5% downside envelope ($515 hard stop) versus 24-33% upside ($675/$725 base/bull cases) justifies patience over premature deployment.
| Position | Action |
|---|---|
| Position target | 50-75% of intended overweight allocation pending technical confirmation |
| Hard stop | $515 below 52-week low on any position initiated |
META is a best-in-class compounder trading at a PEG of 0.88 with accelerating revenue growth (27.9% YoY), a fortress balance sheet ($90B cash, 0.43x D/E), and a fear premium from transitory headline overhangs that historically marks a buying zone—not an exit.
| Indicator | Value | Signal |
|---|---|---|
| close_200_sma | 624.89 | bearish |
| close_50_sma | 594.92 | bearish |
| close_10_ema | 578.90 | bearish |
| macd | -9.80 | bearish |
| macd_histogram | -3.19 | bearish |
| rsi | 36.20 | bearish |
| bollinger_lower_band | 544.97 | bearish |
| atr | 22.18 | neutral |
| volume | 26.55M | bearish |
| close | 543.67 | bearish |
Support: 539.03 · 544.97 | Resistance: 578.9 · 585.82 · 594.92 · 624.89 · 626.67
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Close above $625 (200 SMA) with volume AND constructive trial progression
Then: Upgrade to Overweight
The $1.4T trial figure is a litigation marketing headline, not a probability-weighted outcome; realistic worst case is $30-50B over 10 years (5-7% earnings hit already in the price).
↩ rebuts: “Binary legal risk with potential $1.4T liability”
EV: +29% (12-month target $700 from $543) · concedes: $1.4T is the theoretical maximum damages; bear case is right that there is real legal exposure, even if the probability of max outcome is near zero; FCF compression is real and will persist as long as AI capex remains elevated; 2027 FCF recovery is not guaranteed; The 200 SMA at $624.89 represents meaningful technical resistance on any reclaim attempt; Polymarket 85% probability of zero Fed cuts in 2026 could pressure growth multiples broadly; Recession risk, while currently 8% by year-end, is not zero and ad budgets would contract in a hard landing
META's setup is broken-trend on accelerating momentum with binary legal risk and unproven AI capex consuming 91% of FCF; the asymmetric risk is DOWN until multiple contingent conditions (trial resolution, capex moderation, macro easing) are met for re-rating.
· concedes: $1.4T theoretical maximum is conceded as theoretical (no judge awards $1.4T); Reddit's $1.5-2B ad revenue is 'rounding error' vs. Meta's $60B quarterly print; $30B cash fine is absorbable (but behavioral remedies are not); PEG below 1 is technically 'cheap' — but heading toward fair value if estimates are cut
→ vs conservative: Treating the $1.4 trillion trial headline as a base case rather than a theoretical ceiling separated from realistic outcomes by an order of magnitude
→ vs conservative: Advocating to wait for technical confirmation (reclaiming 10 EMA at 578) means missing the entry and chasing 7% higher
→ vs neutral: Hold with positive bias position requires paying more in every wait-for-clarity scenario (Q3 2026 capex narrative, trial midpoint in 2-3 weeks, technical reclaim at 626)
→ vs neutral: 91% FCF collapse analysis glosses over the fact that OCF grew 25% YoY — the headline FCF number is misleading and reflects intentional investment, not business deterioration
→ vs neutral: Internal tension between acknowledging strong fundamentals and recommending a weak action is paralysis, not analysis
META has declined approximately -20.2% from its July 15, 2026 peak of 681.31 to the current close of 543.67. The August 18 session featured a bearish gap-down (open 557.31, low 543.21, close 543.67) on elevated volume of 26.55M shares. The 10 EMA is now below the 50 SMA, which is below the 200 SMA—a textbook bearish MA stack with all three averages sloping downward. MACD histogram expanded from -0.95 to -3.19, indicating accelerating bearish momentum rather than capitulation. RSI at 36.20 is approaching but not yet at extreme oversold levels seen during the July 30 capitulation (RSI bottomed at 32.12). Price closed below the lower Bollinger Band (544.97), a strong bearish signal. ATR of 22.18 reflects elevated volatility requiring wider stops and reduced position sizing. Support sits at 539.03 (July 30 capitulation low) and 544.97 (Bollinger lower band); resistance clusters at 578.90 (10 EMA), 585.82 (Bollinger middle), 594.92 (50 SMA), 624.89 (200 SMA), and 626.67 (Bollinger upper band). Final recommendation is HOLD with a bearish bias—do not initiate new longs; short positions may be held with trailing stops at approximately 582.
Market Cap
$1.385T
52-Week High
$790.80
52-Week Low
$520.26
Beta
1.243
TTM P/E
20.5x
Forward P/E
15.6x
PEG Ratio
0.88
Price / Book
5.30x
Dividend Yield
0.37%
50-Day Moving Average
$595.96
200-Day Moving Average
$626.72
Revenue (TTM)
$228.25B
Revenue YoY (Latest Q)
+27.9%
Gross Profit (TTM)
$186.59B (~81.7%)
Gross Margin
81.7%
EBITDA (TTM)
$109.66B (~48.0%)
Operating Margin (TTM)
34.8%
Operating Income (Q2 2026)
$18.78B
Operating Margin (Q2 2026)
30.9%
Net Income (TTM)
$68.10B
Net Margin (TTM)
29.8%
Net Income (Q2 2026)
$15.85B
Net Margin (Q2 2026)
26.1%
ROE (TTM)
29.8%
ROA (TTM)
14.6%
EPS (TTM)
$26.57
Forward EPS
$34.89
EPS YoY (Q2 2026)
-13.4%
Book Value per Share
$102.52
Total Assets (Q2 2026)
$449.96B
Total Liabilities (Q2 2026)
$188.74B
Stockholders' Equity (Q2 2026)
$261.22B
Total Debt (Q2 2026)
$112.32B
Cash & ST Investments (Q2 2026)
$90.26B
Net Debt (Q2 2026)
$68.20B
Current Ratio (Q2 2026)
2.23
Debt/Equity (Q2 2026)
0.43 (43%)
Free Cash Flow (TTM)
$21.55B
Free Cash Flow (Q2 2026)
$1.75B
Operating Cash Flow (TTM)
~$130B
Operating Cash Flow (Q2 2026)
$31.86B
CapEx (Q2 2026)
$30.12B
R&D (Q2 2026)
$21.66B
R&D % of Revenue (Q2 2026)
35.6%
SG&A (Q2 2026)
$9.04B
Net PPE (Q2 2026)
$249.7B
Construction in Progress (Q2 2026)
$80.3B
Q2 2026 Revenue
$60.80B
Q1 2026 Revenue
$56.31B
Q4 2025 Revenue
$59.89B
Q3 2025 Revenue
$51.24B
Q2 2025 Revenue
$47.52B
Advertising Revenue (Q2 2026)
$59.79B
Advertising as % of Revenue
97.5%
Interest Income (Q2 2026)
$859M
Interest Expense (Q2 2026)
$783M
Dividend Paid (Q2 2026)
$1.35B
Annual Dividend per Share
$2.10
Strengths
Concerns
Meta Platforms remains a fundamentally elite digital advertising platform generating $228.25B in TTM revenue with best-in-class 29.8% net margin and ~31% expected EPS growth, though Q2 2026 revealed a significant strategic pivot as R&D jumped to 35.6% of revenue and capex surged to $30.12B to fund AI infrastructure, temporarily compressing FCF to $1.75B while operating cash flow held at $31.86B; the stock trades at a compelling forward P/E of 15.6x (PEG 0.88) ~30% below its 52-week high of $790.80, with the primary investment risk being whether management's aggressive AI capex translate to ad-revenue ROI and margin recovery, warranting a HOLD until Q3 2026 capex guidance provides clarity on the sustainability of this capital deployment strategy.